curculigoside has been researched along with Colitis, Ulcerative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, X; Huang, H; Ji, L; Jiang, J; Li, F; Lu, D; Zhao, P | 1 |
| Bai, X; Liu, W; Wang, J; Wang, S | 1 |
2 other study(ies) available for curculigoside and Colitis, Ulcerative
| Article | Year |
|---|---|
Curculigoside mitigates dextran sulfate sodium‑induced colitis by activation of KEAP1‑NRF2 interaction to inhibit oxidative damage and autophagy of intestinal epithelium barrier.
Topics: Animals; Autophagy; Caco-2 Cells; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Humans; Hydrogen Peroxide; Intestinal Mucosa; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Tumor Necrosis Factor-alpha | 2023 |
Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4.
Topics: Animals; Benzoates; Blotting, Western; Cell Line; Colitis, Ulcerative; Colon; Ferroptosis; Glucosides; Iron; Male; Mice; Mice, Inbred C57BL; Phospholipid Hydroperoxide Glutathione Peroxidase; Rats; Real-Time Polymerase Chain Reaction | 2020 |